Clinical benefit of two-times-per-day aclidinium bromide compared with once-a-day tiotropium bromide hydrate in COPD: a multicentre, open-label, randomised study

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is mainly treated pharmaceutically with bronchodilators. The purpose of this study was to evaluate the clinical benefits of two-times-per-day aclidinium bromide (Acli-BID) compared with once-a-day tiotropium bromide hydrate (Tio-QD) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamei, Tadashi, Nakamura, Hiroyuki, Nanki, Nobuki, Minakata, Yoshiaki, Matsunaga, Kazuto, Mori, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661652/
https://www.ncbi.nlm.nih.gov/pubmed/31350236
http://dx.doi.org/10.1136/bmjopen-2018-024114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661652/
https://www.ncbi.nlm.nih.gov/pubmed/31350236
http://dx.doi.org/10.1136/bmjopen-2018-024114

Ejemplares similares